A simple intervention, similar to the tension applied to the arm during a blood pressure reading, is being tested to see if it can reduce the risk of heart failure in cancer survivors treated with common cancer drugs, anthracyclines 

A phase II clinical trial to test the intervention has already recruited 355 people, with 608 patients across Europe expected to take part across six countries and 22 hospitals 

This is the first time an intervention has been offered to cancer patients during their treatment that could reduce their long-term chances of heart failure 

3 million Europeans receive anthracyclines as part of their cancer treatment each year. One million people in Europe are currently living with chronic heart failure following cancer therapy-related heart damage, or cardiotoxicity. 

The National Heart Centre Singapore (NHCS) and Mayo Clinic have collaborated under a Memorandum of Understanding (MOU) to accelerate cardiovascular innovation and research, and to foster knowledge for future cardiovascular care worldwide. This is a result of a two-day scientific meeting between the two organisations, which is supported by the Tanoto Foundation - an independent family foundation that catalyses system changes in education, healthcare and leadership development.

A study of microplastics in U.S. coastal waters found that residents of counties adjacent to the most heavily microplastic-polluted waters had significantly higher rates of Type 2 diabetes, coronary artery disease (plaque-clogged blood vessels feeding the heart) and stroke compared to similar counties located near waters with low levels of microplastic pollution.

Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian partner the Medizinische Universität Wien, which aims to be the first device for monitoring cardiac function and early diagnosis of cardiac tamponade, a life-threatening complication after heart surgery. 

CRF announced the lineup of Late-Breaking Clinical Trials to be presented at New York Valves: The Structural Heart Summit taking place June 25-27, 2025, at the Jacob K. Javits Convention Center, North in New York, NY.

Researchers at Mass General Brigham, in collaboration with the U.S. Department of Veterans Affairs (VA), developed an AI tool called AI-CAC that analyzes routine chest CT scans to identify individuals at risk for cardiovascular events by detecting coronary artery calcium (CAC). The tool, shown to be highly accurate and predictive of 10-year mortality, could enable earlier intervention and help repurpose millions of existing CT scans for proactive heart disease prevention.

For both men and women without a Bachelor’s degree (BA), a new study in JAMA Health Forum found that mortality between 2011-2023 was markedly higher than would have been expected had death rates from 2006-2010 continued. Among 564,855 excess deaths in 2023 alone, 481,211 occurred among people without a BA—a 26 percent increase in mortality among this population, compared to pre-2010 trends. In contrast, mortality only increased by eight percent among people who received a BA.